Suppr超能文献

参与调节铁通过网状内皮细胞转运的因素。

Factors involved in the regulation of iron transport through reticuloendothelial cells.

作者信息

Siegenberg D, Baynes R D, Bothwell T H, MacFarlane B J, Lamparelli R D

机构信息

Department of Medicine, University of the Witwatersrand Medical School, Johannesburg, South Africa.

出版信息

Proc Soc Exp Biol Med. 1990 Jan;193(1):65-72. doi: 10.3181/00379727-193-42992.

Abstract

The effects of various maneuvers on the handling of 59Fe-labeled heat-damaged red cells (59Fe HDRC) by the reticuloendothelial system were studied in rats. Raising the saturation of transferrin with oral carbonyl iron had little effect on splenic release of 59Fe but markedly inhibited hepatic release. Splenic 59Fe release was, however, inhibited by the prior administration of unlabeled HDRC or by the combination of carbonyl iron and unlabeled HDRC. When carbonyl iron was administered with unlabeled free hemoglobin, the pattern of 59Fe distribution was the same as that observed when carbonyl iron was given alone. 59Fe ferritin was identified in the serum after the administration of 59Fe HDRC but the size of the fraction was not affected by raising the saturation of transferrin. Sizing column analyses of tissue extracts from the spleen at various times after the administration of 59Fe HDRC revealed a progressive shift from hemoglobin to ferritin, with only small amounts present in a small molecular weight fraction. The small molecular weight fraction was greater in hepatic extracts, with the difference being marked in animals that had received prior carbonyl iron. The increased hepatic retention of 59Fe associated with a raised saturation of transferrin was reduced by a hydrophobic ferrous chelator (2,2'-bipyridine), a hydrophilic ferric chelator (desferrioxamine), and an extracellular hydrophilic ferric chelator (diethylene-triaminepentacetic acid). Transmembrane iron transport did not seem to be a rate-limiting factor in iron release, since no differences in 59Fe membrane fractions were noted in the different experimental settings. These findings are consistent with a model in which RE cells release iron from catabolized red cells at a relatively constant rate. When the saturation of transferrin is raised, a significant proportion of the iron is transported from the spleen to the liver either in small molecular weight complexes or in ferritin. Although a saturated transferrin had no effect on the release of iron from reticuloendothelial cells, prior loading with HDRC conditions them to release less iron.

摘要

在大鼠中研究了各种操作对网状内皮系统处理59Fe标记的热损伤红细胞(59Fe HDRC)的影响。口服羰基铁提高转铁蛋白饱和度对脾脏释放59Fe影响不大,但显著抑制肝脏释放。然而,预先给予未标记的HDRC或羰基铁与未标记的HDRC联合使用可抑制脾脏59Fe释放。当羰基铁与未标记的游离血红蛋白一起给药时,59Fe分布模式与单独给予羰基铁时观察到的相同。给予59Fe HDRC后,血清中鉴定出59Fe铁蛋白,但该组分的大小不受转铁蛋白饱和度升高的影响。对给予59Fe HDRC后不同时间脾脏组织提取物进行分子筛分析显示,从血红蛋白到铁蛋白有逐渐转变,只有少量存在于小分子量组分中。肝脏提取物中的小分子量组分更大,在预先接受羰基铁的动物中差异明显。疏水性亚铁螯合剂(2,2'-联吡啶)、亲水性铁螯合剂(去铁胺)和细胞外亲水性铁螯合剂(二乙烯三胺五乙酸)可减少与转铁蛋白饱和度升高相关的肝脏对59Fe的保留增加。跨膜铁转运似乎不是铁释放的限速因素,因为在不同实验设置中未观察到59Fe膜组分的差异。这些发现与一种模型一致,即网状内皮细胞以相对恒定的速率从分解代谢的红细胞中释放铁。当转铁蛋白饱和度升高时,相当一部分铁以小分子量复合物或铁蛋白的形式从脾脏转运到肝脏。虽然饱和转铁蛋白对网状内皮细胞释放铁没有影响,但预先用HDRC加载会使它们释放的铁减少。

相似文献

2
Effects of chelators on iron uptake and release by the brain in the rat.
Neurochem Res. 1994 Jan;19(1):71-6. doi: 10.1007/BF00966731.
6
The fate of intravenously injected tissue ferritin in pregnant guinea-pigs.
Br J Haematol. 1989 May;72(1):100-5. doi: 10.1111/j.1365-2141.1989.tb07659.x.
8
Effect of iron chelators on placental uptake and transfer of iron in rat.
Am J Physiol. 1987 May;252(5 Pt 1):C477-82. doi: 10.1152/ajpcell.1987.252.5.C477.
9
The effect of transferrin saturation on internal iron exchange.
Proc Soc Exp Biol Med. 1986 Oct;183(1):66-73. doi: 10.3181/00379727-183-42387.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验